2001
CTOS Annual Meeting Posters— Surgery
EPITHELIOID SARCOMA:
CLINICAL BEHAVIOUR OF A RARE SOFT TISSUE SARCOMA
Dario Baratti, Alessandro Gronchi, Paolo Casali, Laura
Lozza, Elisabetta Pennacchioli, Rossella Bertulli, Palma
Dileo, Mario Santinami
Istituto Nazionale per la Cura e lo Studio dei Tumori
OBJECTIVE: Epithelioid sarcoma (ES) is a rare subtype of soft
tissue sarcoma (STS). Distinctive clinical features are the tendency
to be multifocal at presentation and to spread locally at recurrence,
with an higher rate of lymph nodes involvement and in-transit metastasis.
METHODS: Twenty-nine consecutive patients with ES were
observed at our institution from June 1985 to June 2001. Twenty-two
were male and 7 female; median age at the time of first diagnosis
was 29 years (range 9-66). Site of first presentation was the hand
in 12 cases, the upper limb in 5, the foot in 2, the lower limb
in 6 and the trunk in 4. Fourteen out of 29 patients referred after
a median of 3 consecutive relapses (range 1-5), developing multifocal
recurrences in 4 cases, loco-regional nodal involvement in 2 and
distant metastasis in 1. Two patients underwent amputative surgery
before our observation. Primary treatment of choice performed in
our department was wide en-bloc excision, with the aim to obtain
adequate margin of uninvolved tissue in all directions, and to spare
limbs and limbs function as much as possible. Adjuvant RT was administered
to high risk patients in a postoperative fashion.
RESULTS: ES presented as small superficial nodules in 18
cases and this feature was prevalent in distal localization (11/14),
while deep-seated larger masses were more common in the proximal
extremities or in the trunk (8/15). Surgical treatments performed
were: wide excision in 15 patients, re-excision in 8, digit or ray
amputation in 3, major amputation in 3. Surgical margins were rated
as wide in 16 patients and marginal in 5. No residual tumor was
found in any patient who underwent re-excision. Adjuvant therapies
were the following: postoperative RT in 8 patients, preoperative
limb perfusion in 5, preoperative conventional CT in 4 and postoperative
CT in 1. Median follow-up of the series was 32 months (range 3-181).
Actuarial overall survival at five years was 76.5%; disease free
survival at the same interval was 55.8%. Following treatment at
our Institution, from 1 to 4 consecutive relapses (median 2) occurred
in 12 patients. Recurrence involved loco-regional lymph nodes in
five more patients, thus overall lymph nodal involvement rate was
7 out of 29 (24.1%). Distant metastases were detected at the time
of first presentation in one case, developed as first recurrence
in two and was subsequent to nodal involvement in six. Most common
site of distant metastatization was the lung. All the patients with
metastatic disease are presently died. Four more amputations were
needed to treat local recurrence, thus a total number of 12 such
procedures were performed in 8 patients. Relapse occurred in 3 out
of 15 (20%) patients treated by primitive neoplasm and in 9 out
14 (64.3%) treated for recurrent tumor.
CONCLUSION: . Epithelioid sarcoma is a rare neoplasm, accounting
for less than 1% (29/3376) of all the STS observed during the period
of the study. The present study showed a great propensity to recur
repeatedly and an high rate of nodal involvement was confirmed.
Lack of local control leaded to an increase in amputation rate.
Adequacy of treatment was the most relevant prognostic factor, since
patients referred for recurrent disease, after repeated attempts
of local control, had a worse outcome than patients that underwent
primary treatment in our Department.
|